{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:38:01Z","timestamp":1790951881504,"version":"4.1.0"},"reference-count":99,"publisher":"The Endocrine Society","issue":"Supplement_1","license":[{"start":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006313","name":"Swedish Childhood Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Crown Princess Margareta\u2019s Foundation"},{"name":"Welander Finsen Foundation"},{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY008976"],"award-info":[{"award-number":["EY008976"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY007003"],"award-info":[{"award-number":["EY007003"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Thyroid eye disease (TED) is a complex autoimmune disease process. Orbital fibroblasts represent the central orbital immune target. Involvement of the TSH receptor (TSHR) in TED is not fully understood. IGF-I receptor (IGF-IR) is overexpressed in several cell types in TED, including fibrocytes and orbital fibroblasts. IGF-IR may form a physical and functional complex with TSHR.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Review literature relevant to autoantibody generation in TED and whether these induce orbital fibroblast responses directly through TSHR, IGF-IR, or both.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Evidence<\/jats:title>\n                  <jats:p>IGF-IR has traditionally been considered a typical tyrosine kinase receptor in which tyrosine residues become phosphorylated following IGF-I binding. Evidence has emerged that IGF-IR possesses kinase-independent activities and can be considered a functional receptor tyrosine kinase\/G-protein-coupled receptor hybrid, using the G-protein receptor kinase\/\u03b2-arrestin system. Teprotumumab, a monoclonal IGF-IR antibody, effectively reduces TED disease activity, proptosis, and diplopia. In addition, the drug attenuates in vitro actions of both IGF-I and TSH in fibrocytes and orbital fibroblasts, including induction of proinflammatory cytokines by TSH and TED IgGs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Although teprotumumab has been proven effective and relatively safe in the treatment of TED, many questions remain pertaining to IGF-IR, its relationship with TSHR, and how the drug might be disrupting these receptor protein\/protein interactions. Here, we propose 4 possible IGF-IR activation models that could underlie clinical responses to teprotumumab observed in patients with TED. Teprotumumab is associated with several adverse events, including hyperglycemia and hearing abnormalities. Underpinning mechanisms of these are being investigated. Patients undergoing treatment with drug must be monitored for these and managed with best medical practices.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgac045","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T19:35:41Z","timestamp":1644953741000},"page":"S1-S12","source":"Crossref","is-referenced-by-count":57,"title":["It Takes Two to Tango: IGF-I and TSH Receptors in Thyroid Eye Disease"],"prefix":"10.1210","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0280-9500","authenticated-orcid":false,"given":"Leonard","family":"Girnita","sequence":"first","affiliation":[{"name":"Department of Oncology and Pathology, BioClinicum, Karolinska Institutet and Karolinska University Hospital , 17164 Stockholm , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6279-9685","authenticated-orcid":false,"given":"Terry J","family":"Smith","sequence":"additional","affiliation":[{"name":"Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School , Ann Arbor, MI 48105 , USA"},{"name":"Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan Medical School , Ann Arbor, MI 48105 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9363-6408","authenticated-orcid":false,"given":"Joseph A M J L","family":"Janssen","sequence":"additional","affiliation":[{"name":"Erasmus Medical Center, Department of Internal Medicine, Division of Endocrinology , Dr. Molewaterplein 40, 3015 GD Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,2,15]]},"reference":[{"issue":"10","key":"2022110816330898800_CIT0001","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1210\/jc.2014-1322","article-title":"The thyroid-related quality of life measure ThyPRO has good responsiveness and ability to detect relevant treatment effects","volume":"99","author":"Watt","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2022110816330898800_CIT0002","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol."},{"issue":"16","key":"2022110816330898800_CIT0003","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves\u2019 disease","volume":"375","author":"Smith","year":"2016","journal-title":"N Engl J Med."},{"issue":"4","key":"2022110816330898800_CIT0004","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/cen.14296","article-title":"Prevalence of thyroid eye disease in Graves\u2019 disease: a meta-analysis and systematic review","volume":"93","author":"Chin","year":"2020","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"3","key":"2022110816330898800_CIT0005","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/thy.2014.0475","article-title":"Role of the underlying thyroid disease on the phenotype of Graves\u2019 orbitopathy in a tertiary referral center","volume":"25","author":"Leo","year":"2015","journal-title":"Thyroid."},{"issue":"10","key":"2022110816330898800_CIT0006","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/BF03350047","article-title":"More on smoking habits and Graves\u2019 ophthalmopathy","volume":"12","author":"Bartalena","year":"1989","journal-title":"J Endocrinol Invest."},{"key":"2022110816330898800_CIT0007","article-title":"The risk factors for Graves\u2019 ophthalmopathy","author":"Cao","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"issue":"4","key":"2022110816330898800_CIT0008","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00002341-199907000-00007","article-title":"The effect of cigarette smoke constituents on the expression of HLA-DR in orbital fibroblasts derived from patients with Graves ophthalmopathy","volume":"15","author":"Mack","year":"1999","journal-title":"Ophthalmic Plast Reconstr Surg."},{"issue":"2","key":"2022110816330898800_CIT0009","first-page":"542","article-title":"The incidence of ophthalmopathy after radioiodine therapy for Graves\u2019 disease: prognostic factors and the role of methimazole","volume":"79","author":"Kung","year":"1994","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022110816330898800_CIT0010","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1210\/jc.2009-2130","article-title":"Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent graves\u2019 orbitopathy: a retrospective cohort study","volume":"95","author":"Lai","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"3-4","key":"2022110816330898800_CIT0011","first-page":"177","article-title":"Development and course of exophthalmos and ophthalmoplegia in Graves\u2019 disease with special reference to the effect of thyroidectomy","volume":"5","author":"Rundle","year":"1945","journal-title":"Clin Sci."},{"issue":"2","key":"2022110816330898800_CIT0012","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/jc.2018-01493","article-title":"Potential roles of CD34+ fibrocytes masquerading as orbital fibroblasts in thyroid-associated ophthalmopathy","volume":"104","author":"Smith","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"2022110816330898800_CIT0013","doi-asserted-by":"crossref","first-page":"(52):e2114244118","DOI":"10.1073\/pnas.2114244118","article-title":"Therapeutic IGF-I receptor inhibition alters fibrocyte immune phenotype in thyroid-associated ophthalmopathy","volume":"118","author":"Fernando","year":"2021","journal-title":"Proc Natl Acad Sci USA."},{"issue":"3","key":"2022110816330898800_CIT0014","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1167\/iovs.14-14002","article-title":"Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy","volume":"55","author":"Wang","year":"2014","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"5","key":"2022110816330898800_CIT0015","first-page":"1120","article-title":"Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves\u2019 ophthalmopathy","volume":"77","author":"de Carli","year":"1993","journal-title":"J Clin Endocrinol Metab."},{"issue":"19","key":"2022110816330898800_CIT0016","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1016\/j.jmb.2016.08.002","article-title":"Regulation, signaling, and physiological functions of G-proteins","volume":"428","author":"Syrovatkina","year":"2016","journal-title":"J Mol Biol."},{"issue":"6","key":"2022110816330898800_CIT0017","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1124\/mol.63.6.1256","article-title":"The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints","volume":"63","author":"Fredriksson","year":"2003","journal-title":"Mol Pharmacol."},{"issue":"1","key":"2022110816330898800_CIT0018","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1210\/en.2008-0878","article-title":"Characterization of thyrotropin receptor antibody-induced signaling cascades","volume":"150","author":"Morshed","year":"2009","journal-title":"Endocrinology."},{"key":"2022110816330898800_CIT0019","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/B978-0-12-417197-8.00003-1","article-title":"Constitutive activities in the thyrotropin receptor: regulation and significance","volume":"70","author":"Kleinau","year":"2014","journal-title":"Adv Pharmacol."},{"issue":"4","key":"2022110816330898800_CIT0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tem.2006.03.008","article-title":"GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling","volume":"17","author":"Reiter","year":"2006","journal-title":"Trends Endocrinol Metab."},{"issue":"185","key":"2022110816330898800_CIT0021","doi-asserted-by":"crossref","first-page":"ra51","DOI":"10.1126\/scisignal.2001707","article-title":"Distinct phosphorylation sites on the \u03b2(2)-adrenergic receptor establish a barcode that encodes differential functions of \u03b2-arrestin","volume":"4","author":"Nobles","year":"2011","journal-title":"Sci Signal."},{"issue":"4","key":"2022110816330898800_CIT0022","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrd.2017.229","article-title":"Biased signalling: from simple switches to allosteric microprocessors","volume":"17","author":"Smith","year":"2018","journal-title":"Nat Rev Drug Discov."},{"key":"2022110816330898800_CIT0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.ircmb.2018.02.006","article-title":"Blurring boundaries: receptor tyrosine kinases as functional G protein-coupled receptors","volume":"339","author":"Crudden","year":"2018","journal-title":"Int Rev Cell Mol Biol."},{"issue":"28","key":"2022110816330898800_CIT0024","doi-asserted-by":"crossref","first-page":"16495","DOI":"10.1074\/jbc.270.28.16495","article-title":"G beta gamma subunits mediate mitogen-activated protein kinase activation by the tyrosine kinase insulin-like growth factor 1 receptor","volume":"270","author":"Luttrell","year":"1995","journal-title":"J Biol Chem."},{"key":"2022110816330898800_CIT0025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/bs.pmbts.2016.04.002","article-title":"Chapter three - ubiquitination and protein turnover of G-protein-coupled receptor kinases in GPCR signaling and cellular regulation","volume":"141","author":"Penela","year":"2016","journal-title":"Prog Mol Biol Transl Sci."},{"key":"2022110816330898800_CIT0026","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fphar.2019.00125","article-title":"GPCR signaling regulation: the role of GRKs and arrestins","volume":"10","author":"Gurevich","year":"2019","journal-title":"Front Pharmacol."},{"issue":"6","key":"2022110816330898800_CIT0027","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1089\/thy.1996.6.627","article-title":"Expression and regulation of G protein-coupled receptor kinase 5 and beta-arrestin-1 in rat thyroid FRTL5 cells","volume":"6","author":"Nagayama","year":"1996","journal-title":"Thyroid."},{"issue":"9","key":"2022110816330898800_CIT0028","first-page":"1138","article-title":"GRK2 and beta-arrestin 1 as negative regulators of thyrotropin receptor-stimulated response","volume":"10","author":"Iacovelli","year":"1996","journal-title":"Mol Endocrinol."},{"issue":"6","key":"2022110816330898800_CIT0029","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1210\/en.2005-0687","article-title":"The human thyrotropin receptor is predominantly internalized by beta-arrestin 2","volume":"147","author":"Frenzel","year":"2006","journal-title":"Endocrinology."},{"issue":"8","key":"2022110816330898800_CIT0030","doi-asserted-by":"crossref","first-page":"e1000172","DOI":"10.1371\/journal.pbio.1000172","article-title":"Persistent cAMP-signals triggered by internalized G-protein-coupled receptors","volume":"7","author":"Calebiro","year":"2009","journal-title":"PLoS Biol."},{"issue":"8","key":"2022110816330898800_CIT0031","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1096\/fj.14-251124","article-title":"\u03b2-Arrestin-1 mediates thyrotropin-enhanced osteoblast differentiation","volume":"28","author":"Boutin","year":"2014","journal-title":"FASEB J."},{"issue":"3","key":"2022110816330898800_CIT0032","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.beem.2011.10.003","article-title":"Immunopathogenesis of Graves\u2019 ophthalmopathy: the role of the TSH receptor","volume":"26","author":"Iyer","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"issue":"10","key":"2022110816330898800_CIT0033","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1210\/jc.2004-0716","article-title":"Immunoglobulins from patients with Graves\u2019 disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor","volume":"89","author":"Smith","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2022110816330898800_CIT0034","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1089\/thy.2009.0447","article-title":"Effects of thyrotropin and thyrotropin-receptor-stimulating Graves\u2019 disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves\u2019 ophthalmopathy patients","volume":"20","author":"van Zeijl","year":"2010","journal-title":"Thyroid."},{"issue":"5","key":"2022110816330898800_CIT0035","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1210\/jc.2011-2890","article-title":"A stimulatory thyrotropin receptor antibody enhances hyaluronic acid synthesis in Graves\u2019 orbital fibroblasts: inhibition by an IGF-I receptor blocking antibody","volume":"97","author":"Kumar","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022110816330898800_CIT0036","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.4049\/jimmunol.181.6.4397","article-title":"Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves\u2019 disease","volume":"181","author":"Tsui","year":"2008","journal-title":"J Immunol."},{"issue":"39","key":"2022110816330898800_CIT0037","doi-asserted-by":"crossref","first-page":"26447","DOI":"10.1074\/jbc.M109.003616","article-title":"Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction","volume":"284","author":"Zhang","year":"2009","journal-title":"J Biol Chem."},{"issue":"5","key":"2022110816330898800_CIT0038","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/1043-2760(93)90107-P","article-title":"Influence of thyroid hormones on the GH-IGF-I axis","volume":"4","author":"Rodriguez-Arnao","year":"1993","journal-title":"Trends Endocrinol Metab."},{"issue":"3","key":"2022110816330898800_CIT0039","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1172\/JCI113672","article-title":"Thyroid-stimulating hormone and insulin-like growth factor-1 synergize to elevate 1,2-diacylglycerol in rat thyroid cells. Stimulation of DNA synthesis via interaction between lipid and adenylyl cyclase signal transduction systems","volume":"82","author":"Brenner-Gati","year":"1988","journal-title":"J Clin Invest."},{"key":"2022110816330898800_CIT0040","doi-asserted-by":"crossref","first-page":"6780","DOI":"10.1038\/ncomms7780","article-title":"Nedd4-induced monoubiquitination of IRS-2 enhances IGF signalling and mitogenic activity","volume":"6","author":"Fukushima","year":"2015","journal-title":"Nat Commun."},{"issue":"5","key":"2022110816330898800_CIT0041","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1210\/me.2013-1377","article-title":"Wnt-independent role of \u03b2-catenin in thyroid cell proliferation and differentiation","volume":"28","author":"Sastre-Perona","year":"2014","journal-title":"Mol Endocrinol."},{"issue":"12","key":"2022110816330898800_CIT0042","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1210\/en.2015-1464","article-title":"Disrupted TSH receptor expression in female mouse lung fibroblasts alters subcellular IGF-1 receptor distribution","volume":"156","author":"Atkins","year":"2015","journal-title":"Endocrinology."},{"issue":"12","key":"2022110816330898800_CIT0043","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1210\/endo.142.12.8534","article-title":"Low TSH requirement and goiter in transgenic mice overexpressing IGF-I and IGF-Ir receptor in the thyroid gland","volume":"142","author":"Cl\u00e9ment","year":"2001","journal-title":"Endocrinology."},{"issue":"12","key":"2022110816330898800_CIT0044","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1096\/fj.13-231381","article-title":"IGF-1 receptor deficiency in thyrocytes impairs thyroid hormone secretion and completely inhibits TSH-stimulated goiter","volume":"27","author":"Ock","year":"2013","journal-title":"FASEB J."},{"issue":"1","key":"2022110816330898800_CIT0045","first-page":"3","article-title":"Insulin-like growth factors and their binding proteins: biological actions","volume":"16","author":"Jones","year":"1995","journal-title":"Endocr Rev."},{"issue":"3","key":"2022110816330898800_CIT0046","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/onc.2011.239","article-title":"Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor","volume":"31","author":"Girnita","year":"2012","journal-title":"Oncogene."},{"issue":"10","key":"2022110816330898800_CIT0047","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.bbapap.2012.11.011","article-title":"Insulin receptor-related receptor as an extracellular pH sensor involved in the regulation of acid-base balance","volume":"1834","author":"Petrenko","year":"2013","journal-title":"Biochim Biophys Acta."},{"key":"2022110816330898800_CIT0048","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1042\/bj3270209","article-title":"Insulin receptor\/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting","volume":"327 (Pt 1)","author":"Bailyes","year":"1997","journal-title":"Biochem J."},{"issue":"6","key":"2022110816330898800_CIT0049","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1210\/er.2008-0047","article-title":"Insulin receptor isoforms and insulin receptor\/insulin-like growth factor receptor hybrids in physiology and disease","volume":"30","author":"Belfiore","year":"2009","journal-title":"Endocr Rev."},{"issue":"3-4","key":"2022110816330898800_CIT0050","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000095523","article-title":"The role of insulin-like growth factor binding proteins","volume":"83","author":"Holly","year":"2006","journal-title":"Neuroendocrinology."},{"key":"2022110816330898800_CIT0051","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fendo.2015.00064","article-title":"Targeting the IGF-1R: the tale of the tortoise and the hare","volume":"6","author":"Crudden","year":"2015","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"13","key":"2022110816330898800_CIT0052","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s00018-013-1514-y","article-title":"Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation","volume":"71","author":"Girnita","year":"2014","journal-title":"Cell Mol Life Sci."},{"issue":"37","key":"2022110816330898800_CIT0053","doi-asserted-by":"crossref","first-page":"26091","DOI":"10.1074\/jbc.274.37.26091","article-title":"The role of individual SH2 domains in mediating association of phospholipase C-gamma1 with the activated EGF receptor","volume":"274","author":"Chattopadhyay","year":"1999","journal-title":"J Biol Chem."},{"issue":"26","key":"2022110816330898800_CIT0054","doi-asserted-by":"crossref","first-page":"15639","DOI":"10.1074\/jbc.270.26.15639","article-title":"Non-SH2 domains within insulin receptor substrate-1 and SHC mediate their phosphotyrosine-dependent interaction with the NPEY motif of the insulin-like growth factor I receptor","volume":"270","author":"Craparo","year":"1995","journal-title":"J Biol Chem."},{"issue":"35","key":"2022110816330898800_CIT0055","doi-asserted-by":"crossref","first-page":"29713","DOI":"10.1074\/jbc.M112.393074","article-title":"Phosphatidylinositol 3-kinase (PI3K) activity bound to insulin-like growth factor-I (IGF-I) receptor, which is continuously sustained by IGF-I stimulation, is required for IGF-I-induced cell proliferation","volume":"287","author":"Fukushima","year":"2012","journal-title":"J Biol Chem."},{"issue":"1","key":"2022110816330898800_CIT0056","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bbrc.2012.05.093","article-title":"Insulin\/insulin-like growth factor (IGF) stimulation abrogates an association between a deubiquitinating enzyme USP7 and insulin receptor substrates (IRSs) followed by proteasomal degradation of IRSs","volume":"423","author":"Yoshihara","year":"2012","journal-title":"Biochem Biophys Res Commun."},{"issue":"5","key":"2022110816330898800_CIT0057","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/j.1460-2075.1993.tb05842.x","article-title":"The SH2\/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling","volume":"12","author":"Skolnik","year":"1993","journal-title":"EMBO J."},{"issue":"1","key":"2022110816330898800_CIT0058","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.cr.7290105","article-title":"MAPK signal pathways in the regulation of cell proliferation in mammalian cells","volume":"12","author":"Zhang","year":"2002","journal-title":"Cell Res."},{"issue":"23","key":"2022110816330898800_CIT0059","doi-asserted-by":"crossref","first-page":"6541","DOI":"10.1002\/j.1460-2075.1996.tb01045.x","article-title":"Mechanism of activation of protein kinase B by insulin and IGF-1","volume":"15","author":"Alessi","year":"1996","journal-title":"EMBO J."},{"issue":"3","key":"2022110816330898800_CIT0060","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","article-title":"AKT\/PKB signaling: navigating the network","volume":"169","author":"Manning","year":"2017","journal-title":"Cell."},{"issue":"12","key":"2022110816330898800_CIT0061","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.tips.2007.09.007","article-title":"GPCR-jacking: from a new route in RTK signalling to a new concept in GPCR activation","volume":"28","author":"Delcourt","year":"2007","journal-title":"Trends Pharmacol Sci."},{"issue":"1","key":"2022110816330898800_CIT0062","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ghir.2014.10.002","article-title":"The dichotomy of the Insulin-like growth factor 1 receptor: RTK and GPCR: friend or foe for cancer treatment?","volume":"25","author":"Crudden","year":"2015","journal-title":"Growth Horm IGF Res."},{"issue":"13","key":"2022110816330898800_CIT0063","doi-asserted-by":"crossref","first-page":"6134","DOI":"10.1016\/S0021-9258(18)68760-5","article-title":"Pertussis toxin treatment attenuates some effects of insulin in BC3H-1 murine myocytes","volume":"263","author":"Luttrell","year":"1988","journal-title":"J Biol Chem."},{"issue":"4","key":"2022110816330898800_CIT0064","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1074\/jbc.275.4.2255","article-title":"Association of heterotrimeric G(i) with the insulin-like growth factor-I receptor. Release of G(betagamma) subunits upon receptor activation","volume":"275","author":"Hallak","year":"2000","journal-title":"J Biol Chem."},{"key":"2022110816330898800_CIT0065","doi-asserted-by":"crossref","first-page":"(10)","DOI":"10.3390\/cells8101223","article-title":"Below the surface: IGF-1R therapeutic targeting and its endocytic journey","volume":"8","author":"Crudden","year":"2019","journal-title":"Cells."},{"issue":"18","key":"2022110816330898800_CIT0066","doi-asserted-by":"crossref","first-page":"7055","DOI":"10.1073\/pnas.1118359109","article-title":"Selective recruitment of G protein-coupled receptor kinases (GRKs) controls signaling of the insulin-like growth factor 1 receptor","volume":"109","author":"Zheng","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"issue":"50","key":"2022110816330898800_CIT0067","doi-asserted-by":"crossref","first-page":"20620","DOI":"10.1073\/pnas.1216348110","article-title":"\u03b2-Arrestin-biased agonism as the central mechanism of action for insulin-like growth factor 1 receptor-targeting antibodies in Ewing\u2019s sarcoma","volume":"109","author":"Zheng","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"issue":"47","key":"2022110816330898800_CIT0068","doi-asserted-by":"crossref","first-page":"82256","DOI":"10.18632\/oncotarget.19286","article-title":"Enhanced response of melanoma cells to MEK inhibitors following unbiased IGF-1R down-regulation","volume":"8","author":"Suleymanova","year":"2017","journal-title":"Oncotarget."},{"issue":"15","key":"2022110816330898800_CIT0069","doi-asserted-by":"crossref","first-page":"11329","DOI":"10.1074\/jbc.M611526200","article-title":"Beta-arrestin and Mdm2 mediate IGF-1 receptor-stimulated ERK activation and cell cycle progression","volume":"282","author":"Girnita","year":"2007","journal-title":"J Biol Chem."},{"issue":"2","key":"2022110816330898800_CIT0070","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1158\/0008-5472.CAN-20-1662","article-title":"Inhibition of G protein-coupled receptor Kinase 2 promotes unbiased downregulation of IGF1 receptor and restrains malignant cell growth","volume":"81","author":"Crudden","year":"2021","journal-title":"Cancer Res."},{"issue":"4","key":"2022110816330898800_CIT0071","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41388-021-02111-x","article-title":"IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma","volume":"41","author":"Song","year":"2022","journal-title":"Oncogene."},{"issue":"23","key":"2022110816330898800_CIT0072","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1038\/onc.2016.472","article-title":"Unbalancing p53\/Mdm2\/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma","volume":"36","author":"Worrall","year":"2017","journal-title":"Oncogene."},{"key":"2022110816330898800_CIT0073","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/bs.pmbts.2016.04.001","article-title":"Chapter seven - when phosphorylation encounters ubiquitination: a balanced perspective on IGF-1R signaling","volume":"141","author":"Girnita","year":"2016","journal-title":"Prog Mol Biol Transl Sci."},{"issue":"41","key":"2022110816330898800_CIT0074","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1038\/onc.2017.179","article-title":"Functional antagonism of \u03b2-arrestin isoforms balance IGF-1R expression and signalling with distinct cancer-related biological outcomes","volume":"36","author":"Suleymanova","year":"2017","journal-title":"Oncogene."},{"issue":"6","key":"2022110816330898800_CIT0075","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1167\/iovs.07-0742","article-title":"Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor","volume":"49","author":"Economou","year":"2008","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"3","key":"2022110816330898800_CIT0076","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1124\/mol.107.040014","article-title":"Insulin-like growth factor type-I receptor-dependent phosphorylation of extracellular signal-regulated kinase 1\/2 but not Akt (protein kinase B) can be induced by picropodophyllin","volume":"73","author":"Vasilcanu","year":"2008","journal-title":"Mol Pharmacol."},{"issue":"6","key":"2022110816330898800_CIT0077","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1053\/j.gastro.2020.08.018","article-title":"The long noncoding RNA CCAT2 induces chromosomal instability through BOP1-AURKB signaling","volume":"159","author":"Chen","year":"2020","journal-title":"Gastroenterology."},{"issue":"1","key":"2022110816330898800_CIT0078","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1210\/er.2018-00066","article-title":"Insulin-like growth factor-I receptor and thyroid-associated ophthalmopathy","volume":"40","author":"Smith","year":"2019","journal-title":"Endocr Rev."},{"issue":"6","key":"2022110816330898800_CIT0079","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/eje.0.1330635","article-title":"Effects of growth hormone and insulin-like growth factor I on the immune system","volume":"133","author":"Auernhammer","year":"1995","journal-title":"Eur J Endocrinol."},{"issue":"2","key":"2022110816330898800_CIT0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1210\/edrv.18.2.0296","article-title":"The somatogenic hormones and insulin-like growth factor-1: stimulators of lymphopoiesis and immune function","volume":"18","author":"Clark","year":"1997","journal-title":"Endocr Rev."},{"issue":"4","key":"2022110816330898800_CIT0081","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1189\/jlb.0404248","article-title":"Insulin-like growth factor-I stimulates IL-10 production in human T cells","volume":"76","author":"Kooijman","year":"2004","journal-title":"J Leukoc Biol."},{"issue":"6","key":"2022110816330898800_CIT0082","first-page":"276","article-title":"Insulin-like growth factor-1 receptor regulation in activated human T lymphocytes","volume":"59","author":"Segretin","year":"2003","journal-title":"Horm Res."},{"issue":"2","key":"2022110816330898800_CIT0083","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1210\/endo-119-2-940","article-title":"Insulin-like growth factor-I stimulates the growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves\u2019-IgG","volume":"119","author":"Tramontano","year":"1986","journal-title":"Endocrinology."},{"issue":"4","key":"2022110816330898800_CIT0084","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/08916939309014643","article-title":"Autoantibodies to IGF-1 binding sites in thyroid associated ophthalmopathy","volume":"16","author":"Weightman","year":"1993","journal-title":"Autoimmunity."},{"issue":"12","key":"2022110816330898800_CIT0085","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.4049\/jimmunol.170.12.6348","article-title":"Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves\u2019 disease is mediated through the insulin-like growth factor I receptor pathway","volume":"170","author":"Pritchard","year":"2003","journal-title":"J Immunol."},{"issue":"2","key":"2022110816330898800_CIT0086","doi-asserted-by":"crossref","first-page":"942","DOI":"10.4049\/jimmunol.168.2.942","article-title":"Igs from patients with Graves\u2019 disease induce the expression of T cell chemoattractants in their fibroblasts","volume":"168","author":"Pritchard","year":"2002","journal-title":"J Immunol."},{"issue":"11","key":"2022110816330898800_CIT0087","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1089\/thy.2017.0472","article-title":"Rebuttal to Smith and Janssen (Thyroid 2017;27:746-747. DOI: 10.1089\/thy.2017.0281)","volume":"27","author":"Neumann","year":"2017","journal-title":"Thyroid."},{"issue":"11","key":"2022110816330898800_CIT0088","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1089\/thy.2017.0281","article-title":"Response to Krieger et al. re: \u201cTSHR\/IGF-1R cross-talk, not IGF-1R stimulating antibodies, mediates Graves\u2019 ophthalmopathy pathogenesis\u201d (Thyroid 2017;27:746-747)","volume":"27","author":"Smith","year":"2017","journal-title":"Thyroid."},{"issue":"2","key":"2022110816330898800_CIT0089","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1210\/jc.2012-1771","article-title":"Autoantibodies to the IGF1 receptor in Graves\u2019 orbitopathy","volume":"98","author":"Minich","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022110816330898800_CIT0090","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1210\/jc.2012-2270","article-title":"Circulating IgGs may modulate IGF-I receptor stimulating activity in a subset of patients with Graves\u2019 ophthalmopathy","volume":"98","author":"Varewijck","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2022110816330898800_CIT0091","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s40618-020-01341-2","article-title":"Putative protective role of autoantibodies against the insulin-like growth factor-1 receptor in Graves\u2019 disease: results of a pilot study","volume":"43","author":"Lanzolla","year":"2020","journal-title":"J Endocrinol Invest."},{"issue":"5","key":"2022110816330898800_CIT0092","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1089\/thy.2018.0089","article-title":"Evidence that Graves\u2019 ophthalmopathy immunoglobulins do not directly activate IGF-1 receptors","volume":"28","author":"Marcus-Samuels","year":"2018","journal-title":"Thyroid."},{"issue":"9","key":"2022110816330898800_CIT0093","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1210\/en.2013-1576","article-title":"Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves\u2019 orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation","volume":"154","author":"Moshkelgosha","year":"2013","journal-title":"Endocrinology."},{"issue":"5","key":"2022110816330898800_CIT0094","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.4049\/jimmunol.173.5.3564","article-title":"Synovial fibroblasts from patients with rheumatoid arthritis, like fibroblasts from Graves\u2019 disease, express high levels of IL-16 when treated with Igs against insulin-like growth factor-1 receptor","volume":"173","author":"Pritchard","year":"2004","journal-title":"J Immunol."},{"issue":"4","key":"2022110816330898800_CIT0095","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N Engl J Med."},{"issue":"20","key":"2022110816330898800_CIT0096","first-page":"1959","article-title":"Teprotumumab for active thyroid eye disease. Reply","volume":"382","author":"Douglas","year":"2020","journal-title":"N Engl J Med."},{"key":"2022110816330898800_CIT0097","doi-asserted-by":"crossref","first-page":"(12)","DOI":"10.3390\/cells8121638","article-title":"Non-coding RNAs in IGF-1R signaling regulation: the underlying pathophysiological link between diabetes and cancer","volume":"8","author":"Chen","year":"2019","journal-title":"Cells."},{"key":"2022110816330898800_CIT0098","doi-asserted-by":"crossref","first-page":"(8)","DOI":"10.3390\/cells8080895","article-title":"Therapeutic targeting of the IGF axis","volume":"8","author":"Osher","year":"2019","journal-title":"Cells."},{"key":"2022110816330898800_CIT0099","first-page":":S0161-6420(21)00818-6","article-title":"Teprotumumab efficacy, safety, and durability in longer-duration thyroid eye disease and re-treatment: OPTIC-X study","author":"Douglas","year":"2021","journal-title":"Ophthalmology."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgac045\/42643459\/dgac045.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/Supplement_1\/S1\/46873444\/dgac045.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/Supplement_1\/S1\/46873444\/dgac045.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T18:13:10Z","timestamp":1667931190000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/107\/Supplement_1\/S1\/6528998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,15]]},"references-count":99,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2022,2,15]]},"published-print":{"date-parts":[[2022,8,8]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgac045","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9,1]]},"published":{"date-parts":[[2022,2,15]]}}}